Poland· PL-100252112
Radirex PLUS
A drugs for constipation product containing preparat ziołowy, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Preparat ziołowy
- Manufacturer
- Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- A06A
- ATC class
- DRUGS FOR CONSTIPATION
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990074723
- gtin05909990074716
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A06A
Drugs for constipation, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3f8901bd-faa6-4090-8043-f37bd3c7bc6e GET /v1/drugs/3f8901bd-faa6-4090-8043-f37bd3c7bc6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "-",
"packaging": "05909990074723 ¦ OTC ¦ Skasowane ¦ 7949\n1 op. 150 g\n05909990074716 ¦ OTC ¦ 68129\n1 butelka 125 g",
"substance": "Rhei radix 5 cz. + Frangulae cortex 4 cz. + Foeniculi fructus 0.5 cz. + Carvi fructus 0.5 cz.",
"common_name": "Preparat ziołowy",
"pl_product_id": "100252112",
"pozwolenie_nr": "00747",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat ziołowy.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.